CYT 013 IL1bQb

Drug Profile

CYT 013 IL1bQb

Alternative Names: Anti-interleukin 1 beta vaccine - Cytos; CYT013-IL1bQb; Type 2 diabetes mellitus virus-like particle vaccine - Cytos

Latest Information Update: 27 Feb 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cytos Biotechnology
  • Class Antihyperglycaemics; Diabetes mellitus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 17 Aug 2011 Suspended - Phase-I/II for Type-2 diabetes mellitus in Germany (SC)
  • 17 Aug 2011 Suspended - Phase-I/II for Type-2 diabetes mellitus in Switzerland (SC)
  • 11 Jun 2009 Phase-I/II clinical trials in Type-2 diabetes mellitus in Switzerland (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top